Madhavi Tripathi

Neurology, Inc

Papers

3

Total Citations

66

H-Index

3

About

Madhavi Tripathi is a pioneering neurosurgeon whose work sits at the intersection of minimally invasive surgery, robotics, and nuclear medicine. Her primary research areas include the surgical treatment of drug-resistant epilepsy, particularly through hemispherotomy, and the optimization of radiopharmaceutical production for PET imaging. Dr. Tripathi’s major contributions are groundbreaking. She introduced the world’s first “bloodless” robotic thermocoagulative hemispherotomy (ROTCH), a technique that leverages robotic guidance to perform disconnection without open incisions, dramatically reducing blood loss and recovery time. Her comparative study on endoscope-assisted hemispherotomy (43 citations) demonstrated that this hybrid, robot-guided approach offers efficacy comparable to open surgery with fewer complications. Beyond the operating room, she developed a novel method to simultaneously produce the PET bone agent ¹⁸F-fluoride and ¹⁸F-FDG in a single cyclotron run, minimizing radiation exposure and streamlining production. This dual-production technique, though less cited, showcases her versatility and commitment to practical innovation. Dr. Tripathi’s work is reshaping epilepsy surgery toward safer, less invasive paradigms, making her a leading voice in the field of functional neurosurgery and a role model for researchers seeking to bridge engineering, imaging, and surgical craft.

Research Focus

Key Achievements

3
H-Index
3
Papers
66
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Endoscope-assisted (with robotic guidance and using a hybrid technique) interhemispheric transcallosal hemispherotomy: a comparative study with open hemispherotomy to evaluate efficacy, complications, and outcome
43 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Neurology, Inc

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago